RAPT Therapeutics, Inc. Stock Split Ratio
RAPT Therapeutics, Inc. had Stock Split Ratio of 12.50% as of 2025-06-16, per its 10-Q filed 2025-11-06.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2025-11-06
- 2025-06-16: Stockholders' Equity Note, Stock Split, Conversion Ratio 12.50%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio |
|---|---|
| 2025-06-16 | 12.50% 10-Q · filed 2025-11-06 |